Article
Transcriptional repression by androgen receptor: roles in castration-resistant prostate cancer
1 Jan 2019
Abstract excerpt
Androgen receptor (AR), a hormonal transcription factor, plays important roles during prostate cancer progression and is a key target for therapeutic interventions. While androgen-deprivation therapies are initially successful in regressing prostate tumors, the disease ultimately comes back as castration-resistant prostate cancer (CRPC) or at the late stage as neuroendocrine prostate cancer (NEPC). CRPC remains...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
